Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Memorial Sloan-Kettering Cancer Center
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
vadacabtagene leraleucel
(JCAR015) / BMS
2141-V11
/ Memorial Sloan-Kettering Cancer Center, Rockefeller University
MCARH109
/ Eureka Therap, BMS, Memorial Sloan-Kettering Cancer Center, Sanofi
nivatrotamab
(GD2xCD3) / Y-mAbs Therap
GD2-GD3 Vaccine
/ Y-mAbs Therap
iCasp9M28z T cell infusion
/ Memorial Sloan-Kettering Cancer Center, Bellicum
